Company intelligence / Profile preview

BioSignal Group

Brooklyn, New York, United Statesbiosignalgroup.com ↗

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

BioSignal Group has developed the microEEG®, a miniature, wireless, FDA-cleared portable EEG system for rapid functional brain monitoring. The technology enables use in emergency rooms, clinics, ambulances, sports fields, and home care. Clinical trials have demonstrated its effectiveness; it eliminates the need for specialized EEG technicians by allowing quick setup by non-specialists with remote neurologist interpretation. Over $5.5M in NIH funding has supported development.

Therapeutic areas: Neurology
Modalities: Device (portable EEG system)
Industry: Physiological Monitoring

Partnerships

National Science Foundation (grant support)National Institutes of Health (grant support)NYU Center for Neural Science

Beyond the preview

Go deeper on BioSignal Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSignal Group.

Explore the full profile